Company / Cash per Share
4D Molecular Therapeutics, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.32
FY2025
5-year range
$1.32 / $7.64
FY2021-FY2025
Trend
-62.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7.64 to $1.32 over the past 2 years.
Based on SEC 10-K filings.
1.32 in FY2025 with a 5-year CAGR of -52.3%.
Declined from $7.64 to $1.32 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -6.8%
- 5-Year CAGR
- -52.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 62.1% year-over-year.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.32 | -62.1% |
| FY2024 | $3.47 | -54.6% |
| FY2023 | $7.64 | +370.0% |
| FY2022 | $1.62 | -71.7% |
| FY2021 | $5.73 | -89.3% |
| FY2020 | $53.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026